The team used a deep-learning AI model to scan mammogram images for signs of breast arterial calcification. These appear as ...

Recent health updates include a rise in measles cases in Texas and New Mexico, expansion of Alnylam's heart disease drug ...

The FDA's approval of Alnylam's heart disease drug expands treatment options in a market poised for growth. Meanwhile, the ...

If your allergies leave you feeling lightheaded or cause chest pain, alert your doctor immediately, Nagarajan said. It could ...

Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...

The approval expands the indication for Amvuttra, which now becomes the first and only therapeutic approved by the FDA for ...

Heart disease patients now have another treatment option. The U.S. Food and Drug Administration has approved Alnylam ...

Alnylam Pharmaceuticals Inc. won expanded US approval for a heart drug that could be the biggest boon yet for the 23-year-old ...

Researchers have created an AI tool to accelerate the development of new disease treatments and demonstrated its potential by identifying an existing drug with the potential to prevent deadly heart ...

Alnylam Pharmaceuticals' shares rose about 7% before the bell on Friday following U.S. approval for its drug for a rare and deadly heart disease, securing an entry into a market dominated by Pfizer's ...

The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...

ADVANCEMENTS in surgical, medical, anaesthetic and intensive care have significantly improved survival rates for children ...